Product Licensing

Hemosol completes agreements to license Cascade technology

Published in Blood Weekly, July 1st, 2004

Hemosol Corp. (HMSL) has entered into definitive license and strategic alliance agreements with ProMetic Biosciences, Inc., a subsidiary of ProMetic Life Sciences, Inc., (PLI), to license the Cascade technology developed by ProMetic and its strategic partner, the American National Red Cross, for the separation of valuable therapeutic proteins from human plasma.

Hemosol will integrate the Cascade technology into its state-of-the-art Meadowpine (Blvd.) facility and intends to sell the resulting products to customers, including the American Red Cross.

"With this new business in place and implementation underway, we have achieved an important milestone...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2004-07-01)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry